Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: design, synthesis and biological evaluation.
Liqiao Shi, Rui Hu, Yanhong Wei, Ying Liang, Ziwen Yang, Shaoyong Ke
Index: Eur. J. Med. Chem. 54 , 549-56, (2012)
Full Text: HTML
Abstract
A series of novel anthranilic diamides derivatives containing aryl-isoxazoline moiety were designed and synthesized as a part of our ongoing search for potential anticancer agents. Their structures were confirmed by (1)H NMR, (13)C NMR and ESI-MS analyses. The preliminary assays showed that some of the compounds displayed moderate to good antitumor activities against human lung cancer (NCI-H460), hepatocellular liver carcinoma (HepG2), gastric cancer (SGC-7901 and BGC-823) and breast epithelial adenocarcinoma (MCF-7) cell lines at μM level, which might be developed as novel lead scaffold for potential anticancer agents.Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Related Compounds
Related Articles:
2015-04-01
[Ecotoxicol. Environ. Saf. 114 , 164-70, (2015)]
2015-01-01
[MAbs 7 , 881-90, (2015)]
2014-08-01
[Pharm. Res. 31(8) , 1946-57, (2014)]
2015-01-01
[Biotechnol. Prog. 31 , 840-8, (2015)]
2014-07-01
[Curr. Eye Res. 39(7) , 686-94, (2014)]